相達生物科技出席香港投資管理有限公司國際耐心資本論壇

Hong Kong, May 23, 2025 – PHASE Scientific proudly participated as a featured company at the inaugural International Forum for Patient Capital, hosted by the Hong Kong Investment Corporation Limited (HKIC) on May 22, 2025. This high-profile event brought together over 400 global investors and industry leaders to discuss the role of patient capital in advancing innovation.
 

Forum Highlights
The forum, organized by HKIC—the HKSAR Government’s sovereign wealth fund—served as a global stage for connecting long-term investors with leading innovators. The event focused on how patient capital can drive the next wave of technological breakthroughs and economic growth, particularly in sectors like healthcare and advanced technology.
 

PHASE Scientific’s Spotlight Moment
PHASE Scientific was selected as one of only eight companies from Hong Kong’s innovation ecosystem to present at the forum. Our Founder and CEO, Ricky delivered a keynote presentation to an audience of over 400 institutional investors and industry partners. He shared how PHASE Scientific’s pioneering urine technology is set to transform healthcare, emphasizing our commitment to building a healthier future through innovation.
 

Ricky’s presentation highlighted our company’s vision, our track record of scientific breakthroughs, and the impact of long-term investment in accelerating our growth. The invitation to speak at this prestigious forum is a strong endorsement from HKIC and underscores PHASE Scientific’s leadership in biotechnology.

The event provided PHASE Scientific with an invaluable opportunity to connect with global investors and strategic partners who share our long-term vision. We are honored to contribute to Hong Kong’s vibrant tech ecosystem and to be recognized as a driving force in the future of healthcare innovation.

PHASE Scientific is dedicated to advancing healthcare through innovative diagnostic technologies, empowering people worldwide to live healthier lives.